At the beginning of the century, it rose to [-] billion US dollars,

, rose to $[-] billion a decade ago.

Qiangniu also pointed out that because the target of drugs is constantly decreasing, this is also one of the main reasons for the increase in cost.

After the data was released, the Internet instantly exploded.

Many netizens are discussing this, and many of them do not believe it.

They said that the cost of a new drug of one billion dollars was inflated, but now it costs three billion dollars?

In the face of doubts from netizens, Johnson & Johnson specially held a press conference to explain this in detail.

Many of these statistics,

They all come from multiple institutions, and they can also be verified with the taxes they pay.

And many pharmaceutical companies also stood up and began to support Johnson & Johnson.

They have listed costs,

Some are slightly lower than what Qiangniu said,

. Some are slightly higher, but in general, it is almost the same,

A new stat.

Johnson & Johnson announced at the press conference-

After obtaining the marketing approval for the drug, there are also production (bbdc) costs, sales costs and taxes.

A new drug priced at US$[-] may have a gross profit of less than [-]%. If the sales volume is lower than expected, the research and development costs will not be recovered.

This is also the reason why for some niche diseases, no pharmaceutical companies are willing to develop special drugs, and they cannot afford to lose

Once you develop it, you have to put it on the market, but if you can't sell it, who is willing to do it?

To put it bluntly, medicine is still a business, and the management of enterprises is not to do good things.

Those pharmaceutical companies that don't pay attention to cost are now bankrupt.

In the past [-] years, many pharmaceutical companies have gone bankrupt, many of them because of too much investment in research and development, which has led to them being unable to make ends meet.

He even took Pfizer as an example, saying that many of the drugs developed by Pfizer failed to sell because of their poor performance after being marketed. In the end, Pfizer applied for it.

bankruptcy protection.

But Johnson & Johnson didn't say why Pfizer's drugs couldn't sell, and didn't mention Fu Liang and Xinming Pharmaceuticals.

After Johnson & Johnson's press conference, many media began to contact Fu Liang.

. For some diseases, because the number of sick people is small, pharmaceutical companies are reluctant to develop special medicines, so is it the same for Fu Liang?

Since Johnson said it,

, except hair and nails, any part of the human body,

After all, the doctor said,

It is possible to grow tumors, that is, cancer!

Assistant Xiao Wang looked at Fu Liang and said, "Boss, do you want me to go to this press conference?

He's just an assistant, is that appropriate?

Fu Liang looked at Xiao Wang: "Why, you don't want to go? 1

"I want to go, but I'm not confident." How could Xiao Wang not want to go? He represents the laboratory and Fu Liang, which means that he will become Fu Liangzhong in the future.

Point-trained management talents.

"If you are not confident, all the reporters can ask are those few questions, you come and ask, and I will tell you how to answer.

Fu Gao leaned on the sofa, ready to make a sample for Xiao Wang.

Xiao Wang looked at the questions from netizens and chose one: "Will the laboratory also develop those special medicines for diseases that are niche in the future?

"Fu Gao answered in the affirmative.

Xiao Wang asked again: "It is said that your laboratory is very profitable. Do you have any explanation for this?"

Fu Liang said with a smile: "Yes, our profits are very high. But I also said that we have to develop some niche diseases that do not make money or even lose money.

The specific medicine.

"We will use the money we earn now to subsidize those unprofitable drug projects to support medicines.

"Only in this way can we develop multiple effective drugs to treat different cancers and solve more problems of some diseases.

"Excuse me, what's the problem with us doing this? Do you also hope that we, like other pharmaceutical companies, will give up the development of those niche medicines for diseases?

Chapter [-]: They are [-] billion dollars, I only need [-] million RM coins

Assistant Xiao Wang answered reporters' questions at the press conference as taught by Fu Liang

None of the reporters knew how to respond.

Instead of Fu Liang, Xiao Wang admitted that he made a lot of money, but said that he would develop more special medicines to treat niche diseases

How do those reporters comment on makeup and make up?say no - should it

Although there is no talk of common prosperity in many countries, there is talk of reducing the gap between the rich and the poor, otherwise there would be no step-by-step taxation.

The more you earn, the more you pay your taxes - the higher.

Many poor people not only do not have to pay taxes, but also enjoy the social benefits brought by the government's tax dollars

After this press conference, Fu Liang was on the hot search again.

This remark also means that Fu Liang will develop special medicines for many niche diseases in the future, which is what everyone wants to see.

In addition, Xiao Wang, instead of Fu Liang, said confidently that the company was making money reasonably and legally. What's the problem?

If you can't use the special medicine we developed to treat the pain, go to your country's political axe.

At least in China, there is no need to worry about this at all.

At present, there are only less than [-] million people in China who are not covered by insurance, and most of them are elderly people.

If not, the children of the elderly can afford it

Not really, there are social welfare agencies to help.

The probability of using the special medicine developed by Fu Liang to treat severe diseases is very small.

At night, Li Xiner was lying in Fu Liang's arms: "Are you only developing special medicines for the treatment of severe diseases such as cancer in the future?

Fu Gao shook his head: "Not necessarily, try to come as needed.

"However, drug research and development are all accidental, and sometimes new drugs are developed without liquid hiding, just like the acne-removing face wash from Xinmei Cosmetics

Li Xiner looked at Fu Liang: "You don't need to develop medicines for Xinmei Cosmetics in the future, it's more important to treat those terminal illnesses.

She suddenly felt that Fu Liang had to take the trouble to develop some new drug additives for the cosmetics company.

, some waste of Fu Liang's talent.

People like Fu Gao should develop medicines and make big money while curing diseases and saving lives.

Anyway, evaluate the hair removal creams that cosmetic companies now have,

, Lighten pigmentation, skin-beautifying creams and acne-removing cleansers, before adding

- These products are enough for the company to grow into a first-class cosmetics company.

Fu Liang smiled and said, "It's alright.

, If I think it is suitable for cosmetics, I will keep it for Xinmei Company.

, like a depilatory cream.

Some medicines are indeed more suitable for cosmetics

Who wants to go to the hospital to see this disease, how embarrassing.

"How about you, have you decided when to manage my company? Or should we set up a holding company for comprehensive management?

Li Xiner shook her head: "It is not suitable to set up a holding company, whether it is Xinming Pharmaceutical or Xinmei Cosmetics, the core is the laboratory you lead.

"Including the newly established sales company, the API production company, it's all the same, and the business is not complicated.

"Set up a holding company, unless it is established in an overseas market, so that you can reasonably and legally avoid tax

The flow of capital is also simpler, you do not

Does that mean it doesn't need to be?

Fu Liang leaned on the sofa: "There is really no need to avoid tax.

The more tax he pays, the more he will be valued and the higher his social status will be.

You see a lot of wealthy people donating money, it sounds good, but it can actually be used to avoid tax.

Get a lot of fame for a small amount of money, so many rich businesses are willing to do that.

Since Li Xiner said that there is no need to set up a holding company, then it is not necessary.

"Fu Liang, you will lose a lot when you develop so many medicines for niche diseases. Will your profits be worth much more than your losses?" Li Xiner was a little worried about this.

Once Fu Gao started to develop special medicines for niche diseases, many people with rare diseases would try every means to get Fu Liang to develop medicines.

Based on her understanding of Fu Liang, Fu Liang would not make the price of medicine particularly expensive, for example, a bottle sells for [-] yuan, but it must be the same as now, a bottle for

The centralized purchase price of the insurance bureau is only two or three thousand

In this way, after the production and sales costs, taxes, and R&D costs are included, it is definitely a loss of money!

What if the company loses too much and the company becomes unable to make ends meet?

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like